Oral administration of Bifidobacterium longum in a gastro-resistant seamless capsule decreases serum phosphate levels in patients receiving haemodialysis

CKJ: Clinical Kidney Journal

Volumn 5, Issue 4, 2012, Pages 373-374

  Ogawa, Tetsuya ^a   Shimada, Mikiko ^b   Nagano, Nobuo ^a,c   Ito, Kyoko ^b   Ando, Tetsuo ^d   Shimomura, Yohnosuke ^d   Ando, Yoshitaka ^d   Otsuka, Kuniaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Heisei Hidaka Clinic   (Japan)

^c Hidaka Research Center   (Japan)

^d Hidaka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; ALFACALCIDOL; CALCITRIOL; CALCIUM CARBONATE; PHOSPHATE; PROBIOTIC AGENT; SEVELAMER;

ANTIBIOTIC RESISTANCE; ARTICLE; BIFIDOBACTERIUM LONGUM; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; GASTRO RESISTANT SEAMLESS CAPSULE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTESTINE FLORA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT INDICATION;

EID: 84864465392     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs072     Document Type: Article

References (7)

1. Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. J Am Med Assoc 2011; 305: 1119-1127
2. Hida M, Aiba Y, Sawamura S et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodia-lysis. Nephron 1996; 74: 349-355 (Pubitemid 26326708)
3. Taki K, Takayama F, Niwa T. Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteine-mia in hemodialysis patients. J Ren Nutr 2005; 15: 77-80 (Pubitemid 40093687)
4. Takayama F, Taki K, Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 2003; 41: S142-S145 (Pubitemid 36278365)
5. Benno Y, Mitsuoka T. Impact of Bifidobacterium longum on human fecal microflora. Microbiol Immunol 1992; 36: 683-694
6. Evenepoel P, Meijers BK, Bammens BR et al. Uremic toxins originating from colonic microbial metabolism. Kidney Int 2009; 114: S12-S19
7. Schepers E, Glorieux G, Vanholder R. The gut: the forgotten organ in uremia? Blood Purif 2010; 29: 130-136